Get the Stockscreener App
25.27
0.16%
-0.03
Amphastar Pharmaceuticals Inc stock is traded at $25.27, with a volume of 258.88K.
It is down -0.16% in the last 24 hours and down -5.57% over the past month.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
See More
Previous Close:
$25.30
Open:
$25.2
24h Volume:
258.88K
Relative Volume:
0.54
Market Cap:
$1.17B
Revenue:
$722.68M
Net Income/Loss:
$134.71M
P/E Ratio:
9.4644
EPS:
2.67
Net Cash Flow:
$109.94M
1W Performance:
+4.47%
1M Performance:
-5.57%
6M Performance:
+3.10%
1Y Performance:
-50.07%
1-Day Range:
$24.93
$25.40
1-Week Range:
$23.90
$25.85
52-Week Range:
$20.39
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Name
Amphastar Pharmaceuticals Inc
Sector
Phone
909-980-9484
Address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
25.27 | 1.18B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
125.34 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.55 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.31 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.34 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
436.34 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Upgrade | Needham | Hold → Buy |
| May-12-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-04-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-22-24 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Nov-17-23 | Initiated | BofA Securities | Neutral |
| Jul-25-23 | Resumed | Jefferies | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Jul-29-22 | Initiated | CapitalOne | Overweight |
| Jan-07-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-08-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-05-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-01-20 | Initiated | Northland Capital | Outperform |
| Mar-13-19 | Downgrade | Needham | Buy → Hold |
| Mar-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-10-18 | Reiterated | Needham | Buy |
| Mar-13-18 | Reiterated | Needham | Buy |
| Dec-01-17 | Reiterated | Needham | Buy |
| Nov-09-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-27-17 | Reiterated | Needham | Buy |
| Mar-14-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-09-16 | Reiterated | Needham | Buy |
| May-10-16 | Reiterated | Needham | Buy |
| Feb-19-16 | Initiated | Wells Fargo | Outperform |
| Jun-19-15 | Reiterated | Needham | Buy |
| Jun-03-15 | Initiated | Raymond James | Strong Buy |
| Jul-21-14 | Initiated | Needham | Buy |
View All
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
Is Amphastar Pharmaceuticals Inc. stock supported by strong cash flowsBreakout Watch & Safe Capital Investment Plans - newser.com
Can Amphastar Pharmaceuticals Inc. stock hit analyst price targetsEarnings Summary Report & Free Community Consensus Stock Picks - newser.com
Can trapped investors hope for a rebound in Amphastar Pharmaceuticals Inc.M&A Rumor & Short-Term High Return Strategies - newser.com
Will Amphastar Pharmaceuticals Inc. stock deliver shareholder value2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com
Real time scanner hits for Amphastar Pharmaceuticals Inc. explainedMarket Movers & Community Driven Trade Alerts - newser.com
Applying Elliott Wave Theory to Amphastar Pharmaceuticals Inc.July 2025 Spike Watch & Reliable Price Breakout Alerts - newser.com
Why Amphastar Pharmaceuticals Inc. stock remains resilientAnalyst Upgrade & Smart Investment Allocation Insights - newser.com
Will Amphastar Pharmaceuticals Inc. (29A) stock recover faster than industry2025 Year in Review & Daily Momentum Trading Reports - newser.com
What momentum shifts mean for Amphastar Pharmaceuticals Inc.Weekly Trend Report & Fast Gain Stock Tips - newser.com
Using Python tools to backtest Amphastar Pharmaceuticals Inc. strategiesVolume Spike & Advanced Technical Signal Analysis - newser.com
Will Amphastar Pharmaceuticals Inc. (29A) stock outperform energy sector in 2025Inflation Watch & Weekly Momentum Stock Picks - newser.com
Can Amphastar Pharmaceuticals Inc. stock maintain growth trajectoryJuly 2025 Macro Moves & Community Verified Swing Trade Signals - newser.com
Backtesting results for Amphastar Pharmaceuticals Inc. trading strategiesEntry Point & AI Powered Buy/Sell Recommendations - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock good for long term investingPortfolio Profit Report & Community Supported Trade Ideas - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock trading at attractive multiplesMarket Trend Review & Precise Buy Zone Tips - newser.com
Key metrics from Amphastar Pharmaceuticals Inc.’s quarterly dataJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com
Should you wait for a breakout in Amphastar Pharmaceuticals Inc.July 2025 Catalysts & Risk Controlled Stock Pick Alerts - newser.com
Multi asset correlation models including Amphastar Pharmaceuticals Inc.2025 Volatility Report & Short-Term Trading Alerts - newser.com
Amphastar Pharmaceuticals, Inc. (AMPH) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Amphastar Pharmaceuticals, Inc. (AMPH) stock forecast and price target - Yahoo! Finance UK
Will Amphastar Pharmaceuticals Inc. (29A) stock beat international competitionDay Trade & Smart Allocation Stock Reports - newser.com
Why Amphastar Pharmaceuticals Inc. (29A) stock could be next leaderQuarterly Profit Review & Proven Capital Preservation Tips - newser.com
Analyzing recovery setups for Amphastar Pharmaceuticals Inc. investorsJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - newser.com
Amphastar Pharmaceuticals Inc Stock (AMPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Amphastar Pharmaceuticals Inc Stock (AMPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Petersen Floyd F. | Director |
Oct 01 '25 |
Sale |
27.20 |
500 |
13,602 |
76,031 |
0.27%
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):